Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modifications of therapy.

W V Kern1

  • 1University Hospital and Medical Center, D-89070 Ulm, Germany. winfried.kern@medizin.uni-ulm.de

International Journal of Antimicrobial Agents
|October 29, 2000
PubMed
Summary
This summary is machine-generated.

Empirical fever therapy in neutropenic patients shows variable response rates. Adjusting treatment based on patient response and specific infections, like adding antifungals or aminoglycosides, improves outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequent high-level rifaximin resistance in <i>Escherichia coli</i> associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled study.

Microbiology spectrum·2025
Same author

Antimicrobial Stewardship in German non-university hospitals: baseline status and impact of a multifaceted AMS intervention within the prospective ID ROLL OUT study.

Infection·2025
Same author

Impact of enhanced infection control and antimicrobial stewardship on infections by Clostridioides difficile, vancomycin-resistant enterococci, and third-generation cephalosporin-resistant Enterobacterales: a stepped-wedge cluster intervention study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025
Same author

Occurrence and trends of Clostridioides difficile infections in hospitalized patients: a prospective multi-centre cohort study in six German university hospitals, 2016-2020.

The Journal of hospital infection·2024
Same author

Vertebral osteomyelitis in patients with Staphylococcus aureus bloodstream infection: Evaluation of risk factors for treatment failure.

The Journal of infection·2021
Same author

Anosmia in COVID-19 patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same journal

Corrigendum to "Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination" [International Journal of Antimicrobial Agents, 57 (2021) 106277].

International journal of antimicrobial agents·2026
Same journal

Ecr positively regulates the activity of the PhoQ/PhoP signaling system in Klebsiella pneumoniae.

International journal of antimicrobial agents·2026
Same journal

Contribution of the Arg-33-His Replacement in the Histidine Kinase CpxA to Carbapenem and Cefiderocol Resistance in Serratia marcescens.

International journal of antimicrobial agents·2026
Same journal

Real world evaluation of HIV-1 reservoir and resistance in virologically suppressed people after 52 weeks of treatment with long-acting cabotegravir + rilpivirine.

International journal of antimicrobial agents·2026
Same journal

Molecular and Epidemiological Characteristics of Cefiderocol-Resistant Klebsiella pneumoniae: A Systematic Review and Genomic Analysis.

International journal of antimicrobial agents·2026
Same journal

Timing and regimen of antiretroviral therapy and all-cause mortality in people with HIV: A time-to-event mediation analysis via opportunistic infection.

International journal of antimicrobial agents·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Hematology
  • Clinical Pharmacy

Background:

  • Fever in neutropenic patients is a critical condition with a wide range of responses to empirical therapy (40-90%).
  • Therapy modifications are often necessary for non-responders and can be considered for responders.
  • Optimizing antimicrobial strategies is crucial for improving patient outcomes.

Purpose of the Study:

  • To review and synthesize current evidence on modifying empirical antimicrobial therapy in febrile neutropenic patients.
  • To provide guidance on when and how to adjust treatment based on clinical response and specific pathogens.
  • To highlight the role of diagnostic tools and risk assessment in tailoring therapy.

Main Methods:

  • Literature review of studies on empirical therapy for febrile neutropenia.

Related Experiment Videos

  • Analysis of treatment modification strategies based on patient response (defervescence, persistent fever).
  • Evaluation of the efficacy of adding specific antimicrobial classes (antifungals, aminoglycosides, glycopeptides).

    • Main Results:

    • Switching to oral therapy is acceptable for patients with unexplained fever and rapid defervescence.
    • Addition of antifungals benefits patients with persistent fever or progressive pneumonia.
    • Empiric glycopeptide addition is generally not effective; aminoglycosides may improve response in gram-negative infections.
    • Narrow-spectrum antimicrobials for defined etiology in persistent neutropenia increase superinfection risk.

    Conclusions:

    • Therapy modifications should be guided by clinical response, diagnostic findings, and specific infection types.
    • Judicious use of antifungals and aminoglycosides can improve outcomes in selected neutropenic patients.
    • Enhanced diagnostic capabilities and risk stratification are key to optimizing antimicrobial therapy and minimizing resistance.